Azenta, Inc.

Azenta, Inc.(AZTA)の株式分析

$34.090

-2.267 (-6.65%)終値時点

Loading chart…
高値
37.368
始値
36.520
出来高加重平均価格
34.83
出来高
1.26M
時価総額
2.81B
安値
33.030
売買代金
43.97M
EV/EBITDA(TTM)
36.27

Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.

www.azenta.com

AI分析 of Azenta, Inc. (AZTA)

中立

Azenta Inc is currently a hold. The stock is priced at $37.72, which is above the analyst price target of $35, indicating potential overvaluation. The recent RSI of 56.115 suggests that the stock is neither overbought nor oversold, but the negative sentiment from ongoing investigations into securities claims could pose risks.

バリュエーション指標

Azenta, Inc.(AZTA)の現在の予想PERは29.07で、5年平均は186.84です。

予想PER

適正
5年平均 P/E
186.84
現在のP/E
29.07
割高
487.64
割安
-113.96

予想EV/EBITDA

適正
5年平均 EV/EBITDA
29.69
現在のEV/EBITDA
36.27
割高
68.04
割安
-8.66

予想PSR

適正
5年平均 P/S
4.86
現在のP/S
2.55
割高
8.06
割安
1.67

Alphio AI による AZTA の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%AZTA

$34.77

シナリオ価格

基

基本

基本 · 50%AZTA

$30.40

シナリオ価格

弱

弱気

弱気 · 25%AZTA

$25.27

シナリオ価格

AZTA を保有するクジラ

A

American Capital Management, Inc.

+ を保有AZTA

+1.32%

3か月リターン

イベントタイムライン

2026-08-24 (ET)

08:30:00

Company Reaffirms Q4 Total Revenue Guidance

08:30:00

Azenta Appoints Martin Madaus as Interim CEO

2026-08-04 (ET)

17:00:00

Company Expects Organic Revenue Flat to Up 1% for FY2025

17:00:00

Company Q3 Revenue Exceeds Expectations at $161M

17:00:00

Total Organic Revenue Expected to Decline in Q4 FY2025

ニュース

AZTA のよくある質問 — Alphio AI が回答

Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software. It operates in the Healthcare sector (SPECIAL INDUSTRY MACHINERY, NEC industry).

Azenta Inc is currently a hold. The stock is priced at $37.72, which is above the analyst price target of $35, indicating potential overvaluation. The recent RSI of 56.115 suggests that the stock is neither overbought nor oversold, but the negative sentiment from ongoing investigations into securities claims could pose risks.

コミュニティ

もっと見る ↗
登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める